4 therapeutic objectives
Faced with the complexity of multiple sclerosis, we have 4 therapeutic objectives
Multiple sclerosis (MS) is the most common neurological disorder among young adults and often results in a handicap. It is an auto-immune disease in which the body attacks its own tissues. The immune attack in MS targets the central nervous system. The lesions are well-localised and are called “plaques”.
Faced with the complexity of multiple sclerosis, we have 4 therapeutic objectives
To overcome MS, it is necessary to better understand the mechanisms of the disease. In university laboratories and research centres, budgets for multiple sclerosis research are limited. Each year, research teams therefore turn to the Belgian Charcot Foundation. A few figures illustrate what a donation means.
No summer at the beach for the Belgian Charcot Foundation. Preparations begin for the Charcot Fund 2023, which will enable experienced researchers in Belgium to launch innovative and pioneering research into multiple sclerosis.
Twice a year, the Charcot Foundation publishes a Bulletin which wants to be the objective reflection of research and last acquisitions in Multiple sclerosis as well in the field of our knowledge of the disease as of the new treatments under study
